Sumitomo Pharma Oncology Alternatives & Competitors
12 companies similar to Sumitomo Pharma Oncology — is part of Sumitomo Pharma America as of July 2023
Companies similar to Sumitomo Pharma Oncology
Tango Therapeutics
Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of preci...
Boston, United States
Prelude Therapeutics
Precision Oncology, Redefined.
Wilmington, United States
AtG Therapeutics
Overcoming Tumor Adaptation - inhibiting escape mechanisms both in treatment naive and res...
Spain
iOmx Therapeutics AG
Developing next-generation targeted cancer immunotherapy treatments
Germany
Rival Readout
Competing with Sumitomo Pharma Oncology? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Day One Biopharmaceuticals
Cancer drug development comes of age.
Brisbane, United States
Chordia Therapeutics Inc
We are passionate to deliver first in class cancer drugs to patients from Japan.
Fujisawa, Japan
iOnctura
Developing precision small molecules to combat hard-to-treat tumors.
Geneve, Switzerland
Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
Oxford, United Kingdom
OncoSpherix
Advanced drugs for advanced cancers
Atlanta, United States
Biomed Valley Discoveries
Biotech, Purposefully Reimagined
Kansas City, United State...
ORIC Pharmaceuticals Inc.
Overcoming Resistance In Cancer
South San Francisco, Unit...
Cedilla Therapeutics
A New Dimension in Precision Oncology
Cambridge, United States
About Sumitomo Pharma Oncology
Sumitomo Pharma Oncology is a subsidiary of the global pharmaceutical company Sumitomo Pharma Co., Ltd., now operating as part of Sumitomo Pharma America (SMPA) as of July 2023. Although the company's standalone pages are inactive, its mission under SMPA reflects a commitment to pioneering drug development in the bioph...
Drug Discovery, Development and Commercialization, Clinical Research, Innovative Treatment Solutions, Science and Technology Advancements
Patients, Healthcare Providers, Caregivers, Medical Institutions
Biopharmaceutical, Cancer Therapeutics, Oncology Research, Clinical Development, Oncogenic Pathways, Survival Mechanisms, Novel Protein Interactions, Drug Discovery, Drug Development, External Innovation, Patient-Centric Innovation, Therapeutic Breakthroughs, Research And Development, Cancer Treatment Resistance, Tumor Progression
B2B, B2G
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Sumitomo Pharma Oncology: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Sumitomo Pharma Oncology on 7 Apr 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
